Meprednisone


Indications and Reactions:

Role Indications Reactions
Secondary
Lupus Nephritis 33.7%
Liver Transplant 22.1%
Systemic Lupus Erythematosus 8.8%
Renal Transplant 8.3%
B-cell Lymphoma 4.4%
Product Used For Unknown Indication 4.4%
Immunosuppression 2.8%
Rheumatoid Arthritis 2.8%
Arthritis 2.2%
Haemolytic Anaemia 2.2%
Hepatitis C 2.2%
Osteoporosis 2.2%
Prophylaxis 1.1%
Blood Triglycerides Increased 0.6%
Chronic Obstructive Pulmonary Disease 0.6%
Dyslipidaemia 0.6%
Hypertension 0.6%
Paroxysmal Nocturnal Haemoglobinuria 0.6%
Viral Infection 21.8%
Pneumonia 14.5%
Systemic Lupus Erythematosus 9.1%
Vaginal Haemorrhage 7.3%
Vomiting 7.3%
Anogenital Warts 5.5%
Febrile Neutropenia 3.6%
Hypothyroidism 3.6%
Peritonitis 3.6%
Tremor 3.6%
Urinary Tract Infection 3.6%
Bronchopulmonary Aspergillosis 1.8%
Haemoglobin Decreased 1.8%
Head Injury 1.8%
Hepatic Failure 1.8%
Muscular Weakness 1.8%
Respiratory Acidosis 1.8%
Respiratory Distress 1.8%
Sepsis 1.8%
Tendon Rupture 1.8%
Concomitant
Rheumatoid Arthritis 30.8%
Prophylaxis 8.5%
Lupus Nephritis 6.0%
Product Used For Unknown Indication 6.0%
Hypertension 5.0%
Arthritis 4.7%
Drug Use For Unknown Indication 4.7%
Joint Swelling 3.9%
Oedema Peripheral 3.9%
Hepatitis C 3.4%
Immunosuppression 3.4%
Osteoarthritis 3.1%
Hypothyroidism 2.9%
Prophylaxis Against Transplant Rejection 2.9%
Osteoporosis 2.7%
Pneumonia 2.3%
Osteopenia 1.6%
Still's Disease Adult Onset 1.6%
Pain 1.4%
Renal Cell Carcinoma Stage Unspecified 1.4%
Urinary Tract Infection 12.5%
Febrile Neutropenia 6.8%
Abdominal Abscess 5.7%
Cataract 5.7%
Iiird Nerve Paresis 5.7%
Immune Thrombocytopenic Purpura 5.7%
Pyrexia 5.7%
Systemic Lupus Erythematosus 5.7%
Acute Myocardial Infarction 4.5%
Osteonecrosis Of Jaw 4.5%
Pleural Effusion 4.5%
Renal Failure 4.5%
Respiratory Tract Infection 4.5%
Appendicitis 3.4%
Cervix Carcinoma 3.4%
Hypersensitivity 3.4%
Liver Disorder 3.4%
Myocardial Infarction 3.4%
Organising Pneumonia 3.4%
Pneumonia 3.4%

Drug Data